rs797044527
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_023067.4(FOXL2):c.650C>T(p.Ser217Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S217C) has been classified as Likely pathogenic.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
FOXL2
NM_023067.4 missense
NM_023067.4 missense
Scores
9
7
3
Clinical Significance
Conservation
PhyloP100: 6.42
Genes affected
FOXL2 (HGNC:1092): (forkhead box L2) This gene encodes a forkhead transcription factor. The protein contains a fork-head DNA-binding domain and may play a role in ovarian development and function. Expansion of a polyalanine repeat region and other mutations in this gene are a cause of blepharophimosis syndrome and premature ovarian failure 3. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.976
PP5
Variant 3-138946073-G-A is Pathogenic according to our data. Variant chr3-138946073-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 180594.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXL2 | NM_023067.4 | c.650C>T | p.Ser217Phe | missense_variant | 1/1 | ENST00000648323.1 | NP_075555.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXL2 | ENST00000648323.1 | c.650C>T | p.Ser217Phe | missense_variant | 1/1 | NM_023067.4 | ENSP00000497217 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1268470Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 623726
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1268470
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
623726
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Ser217 amino acid residue in FOXL2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17277738, 19515849, 22312189). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on FOXL2 function (PMID: 18372316, 19010791). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 180594). This missense change has been observed in individual(s) with blepharophimosis (PMID: 11468277, 31077882). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 217 of the FOXL2 protein (p.Ser217Phe). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 23, 2023 | Published functional studies demonstrate a damaging effect, showing an increased transactivation activity (PMID: 19010791, 19515849, 18372316); Identified in multiple unrelated individuals with features of blepharophimosis-ptosis-epicanthus inversus syndrome referred for genetic testing at GeneDx and in the published literature (PMID: 11468277); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19515849, 18372316, 22312189, 20067892, 19010791, 11468277) - |
Blepharophimosis, ptosis, and epicanthus inversus syndrome Pathogenic:1Other:1
Likely pathogenic, no assertion criteria provided | clinical testing | Wessex Regional Genetics Laboratory, Salisbury District Hospital | Jan 01, 2018 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
L;L
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
.;N
REVEL
Pathogenic
Sift
Uncertain
.;D
Sift4G
Benign
.;T
Polyphen
D;D
Vest4
0.70
MutPred
Loss of glycosylation at S217 (P = 0.0013);Loss of glycosylation at S217 (P = 0.0013);
MVP
0.95
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at